Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 21 Jun 2023 00:12 CEST |
ARGENX SE | argenx Announces U.S. Food and Drug Administration Approval of VYVGART Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) Injection for Subcutaneous Use in Generalized Myasthenia Gravis | 20103010 Biotechnology | Other subject |
| 20 Jun 2023 07:00 CEST |
ARGENX SE | argenx Initiates Second Cohort of Phase 2 ARDA Study of Empasiprubart in Multifocal Motor Neuropathy | 20103010 Biotechnology | Other subject |
| 31 May 2023 07:00 CEST |
ARGENX SE | argenx to Present at Upcoming Investor Conferences | 20103010 Biotechnology | Other subject |